<p>The engineered bacteria we designed will colonize the patient's intestinal tract, achieving long-term regulated secretion for drug delivery, enhancing the stability of treatment and reducing costs. The validation of the colonization system will be conducted from two aspects: the perception of IBD signals and the colonization proteins, verifying both the principles and the results.</p>
